SFG
BSX icon

Strive Financial Group’s Boston Scientific BSX Stock Holding History

Strive Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Sell
3,419
-11,800
-78% -$641K 0.06% 174
2026
Q1 		$955K Sell
15,219
-501
-3% -$40.1K 0.51% 56
2025
Q4 		$1.5M Buy
+15,720
New +$1.54M 0.79% 46

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Strive Financial Group's BSX Position: Q2 2026 in Review

Strive Financial Group reduced its Boston Scientific (BSX) stake by 78% in Q2 2026, selling an estimated $641K and leaving 3,419 shares worth $146K. The position accounts for 0.06% of the portfolio, ranked #174.

Strive Financial Group first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.5M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Strive Financial Group held 3,419 shares of Boston Scientific worth $146K as of Q2 2026.
  • Strive Financial Group sold 11,800 Boston Scientific shares in Q2 2026, an estimated $641K.
  • Boston Scientific made up 0.06% of Strive Financial Group's portfolio in Q2 2026, its #174 holding.
  • Strive Financial Group first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Strive Financial Group's Boston Scientific position peaked at $1.5M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.